Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.095

-4.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kay bryan who wrote (2240)	1/21/2000 7:15:00 PM
From: yosid	Read Replies (2) of 3576

How about this scenario? GERN - generates new cell structures that replace defective cancer cells using patented bio-physics methods. ASTM - able to replicate the new cells in endless quantities. NEXL - able to screen out impurities, and select conforming cells. Ex: Applied to Bone Marrow Cancers ---- Geron produces a modified cell able to replace cancer cells affecting the marrow. ASTM reproduces the cells in quantity. NEXL screens the final product to assure quality and eliminate impurities. I was hoping these companies would talk. If it works for blood, the other possibilities are endless. Any comments on the science out there????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next